Delivery Order SPE2DB24D2205-SPE2DB25FEHJB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for $4,418.88 to supply Xulane 150-35 mcg/day transdermal patches (quantity: 3 units). This is a firm fixed price delivery order with no set-aside designation, completed competitively under the company's larger indefinite delivery contract with DLA Troop Support Medical. The order is set to be fulfilled by the ultimate completion date of August 13, 2025, with the place of performance in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Xulane 150-35 mcg/day transdermal patches (3-count units) valued at $7,555.01. This competitively awarded, firm fixed-price delivery order is set to complete by August 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement under the company's existing federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,339.62 to AmerisourceBergen Drug Corp for the supply of Xulane 150-35 mcg/day transdermal patches (3-count units). This firm fixed-price delivery order, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, was competitively awarded with no set-aside designation. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,038.24 on August 19, 2025, for the supply of Xulane 150-35 mcg/day transdermal patches (3-pack units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation, due for completion by August 20, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child transaction...
- The Defense Logistics Agency awarded a delivery order valued at $3,040.92 to AmerisourceBergen Drug Corp for Xulane 150-35 microgram/day transdermal patches (three-count packaging). This firm fixed-price, non-set-aside contract was executed on August 7, 2025, with an ultimate completion date of August 8, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at approximately $23.8k to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count units). This firm fixed-price, competitively awarded delivery order was issued on August 14, 2025, with an ultimate completion date of August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract contains no set-aside designation. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,435.52 to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day transdermal patches (three-count packages). This firm fixed-price delivery order, issued on August 28, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The order was competitively awarded with no set-aside designation and will be fulfilled from the vendor's location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,642.20 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day patches (quantity: 3) with a firm fixed price structure. The contract, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,179.78 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. As a child contract, this delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for Xulane 150-35 mcg/day transdermal patches (3-pack units) with a ceiling value of $6,836.59 under a firm fixed price contract. This competitively awarded, non-set-aside delivery order is scheduled for completion by August 18, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHJBDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,041.64 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-pack quantity) on September 10, 2025, with completion scheduled for September 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, is fulfilling this order as a child contract under a larger vehicle. This delivery order represents a routine pharmaceutical supply transaction under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, and medical devices—to support military healthcare programs globally. The contractor regularly fulfills similar delivery orders for diverse therapeutic areas, demonstrating its established capability to serve the Defense Health Agency and other federal healthcare systems through competitive federal procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 9/10/25 |